Haleon (NYSE: HLN) starts cash tender offer for 2027 3.375% fixed rate notes
Rhea-AI Filing Summary
Haleon plc has launched a cash tender offer for its outstanding 2027 3.375% Fixed Rate Notes. The company states that this tender offer, together with a planned issue of new bonds, is in line with its previously stated capital allocation priorities and is expected to help proactively manage and optimise its debt portfolio.
The detailed terms of the tender offer are provided in a separate announcement available via the London Stock Exchange and on Haleon’s investor website, and have also been submitted to the UK Financial Conduct Authority’s National Storage Mechanism.
Positive
- None.
Negative
- None.
Key Figures
Coupon Rate: 3.375%
Maturity Year: 2027
2 metrics
Coupon Rate
3.375%
Interest rate on Haleon’s 2027 Fixed Rate Notes targeted by the cash tender offer
Maturity Year
2027
Maturity year of the Fixed Rate Notes subject to the cash tender offer
Key Terms
Cash tender offer, Fixed Rate Notes, capital allocation priorities, National Storage Mechanism
4 terms
Cash tender offer financial
"Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes"
A cash tender offer is a public proposal in which an individual or group offers to buy a set number of a company's shares directly from shareholders for a specified cash price during a limited time. It matters to investors because it gives a clear, immediate chance to sell shares at a known price — like a store offering to buy back items at a posted rate — and can affect the stock’s market price, ownership control and liquidity.
Fixed Rate Notes financial
"cash tender offer for outstanding 2027 3.375% Fixed Rate Notes"
Debt securities that pay a set, unchanging interest rate for a specified period and return the original loan amount at maturity. They matter to investors because they offer predictable income—like a fixed rent check from a building—but their market value can still move with overall interest rates and the issuer’s credit, affecting resale price and risk if you sell before maturity.
capital allocation priorities financial
"This Tender Offer is in line with Haleon's previously stated capital allocation priorities"
Capital allocation priorities are the order in which a company decides to use its financial resources, such as investing in new projects, paying dividends, reducing debt, or saving for future needs. They matter to investors because they influence a company's growth potential and financial stability, helping them understand how the business plans to grow and return value over time. Proper priorities can indicate a well-managed company focused on sustainable success.
National Storage Mechanism regulatory
"will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism"
A national storage mechanism is an official, centralized electronic repository where companies and regulators file and keep required corporate documents such as prospectuses, financial statements and regulatory disclosures. For investors it is the authoritative public source to find and verify key papers — like using a government-run public archive or filing cabinet — so you can check the original documents for due diligence, compliance and to confirm claims made in news or marketing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Haleon plc (HLN) announce in its August 2026 Form 6-K?
Haleon plc announced a cash tender offer for its outstanding 2027 3.375% Fixed Rate Notes. The action aligns with its capital allocation priorities and is paired with a planned new bond issue to manage and optimise its debt portfolio.
Which securities are targeted by Haleon plc’s (HLN) cash tender offer?
The cash tender offer targets Haleon plc’s outstanding 2027 3.375% Fixed Rate Notes. These fixed rate notes carry a 3.375% coupon and mature in 2027, and the offer is part of a broader debt management strategy.
How does Haleon plc (HLN) describe the purpose of the tender offer and new bonds?
Haleon states the tender offer and planned new bond issue are intended to proactively manage and optimise its debt portfolio. The company also notes that these actions are in line with its previously stated capital allocation priorities.
Where can investors find the full details of Haleon plc’s (HLN) tender offer?
Full details are provided in an announcement accessible via a London Stock Exchange RNS PDF link, Haleon’s investor website, and the UK FCA’s National Storage Mechanism, where the unedited text has been submitted for inspection.
Who should investors contact at Haleon plc (HLN) regarding the tender offer?
Investor enquiries can be directed to Haleon’s investor relations team via investor-relations@haleon.com. The filing also lists specific investor, media, and treasury contacts with UK telephone numbers for more detailed questions about the transaction.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
99.1
|
11
August 2026 - “Cash tender offer
- outstanding 2027 3.375% Notes”
|
99.1
Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed
Rate Notes
Note: This announcement is being released in accordance with DTR
6.3.10 R. In the United Kingdom, the Tender Offer is only available
to relevant persons, as described under "Non-U.S. Distribution
Restrictions - United Kingdom" in the full announcement linked
below.
11 August 2026: Haleon
plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today
announces
that its wholly owned subsidiary, Haleon US Capital LLC (the
"Offeror") is offering to buy back any and all of its
outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March
2027. Bondholders will receive a price equal to the Total
Consideration based on the Reference Yield and the Fixed Spread
plus Accrued Interest (each as defined in the full announcement)
(the "Tender Offer").
This Tender Offer is in line with Haleon's previously stated
capital allocation priorities. Together, with the planned issue of
new bonds, it is expected to help the Company to proactively manage
and optimise its debt portfolio. The full announcement is available
at
http://www.rns-pdf.londonstockexchange.com/rns/2411Q_1-2026-8-11.pdf.
The full announcement will also be available on the Haleon
website www.haleon.com/investors,
and has been submitted in full unedited text to the Financial
Conduct Authority's National Storage Mechanism and will shortly be
available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
|
Investors
|
Media
|
||
|
Jo
Russell
|
+44
7787 392441
|
Zoë Bird
|
+44
7736 746167
|
|
Rakesh
Patel
|
+44
7552 484646
|
Gemma
Thomas
|
+44 7985 175048
|
|
Email: investor-relations@haleon.com
|
Email: corporate.media@haleon.com
|
||
|
|
|
||
|
Treasury
|
|
||
|
Mike
Rowe
|
+44
7775 012365
|
|
|
|
Ben
Checkland
|
+44
7823 370368
|
|
|
|
Email: cf-treasury@haleon.com
|
|
||
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date:
August 11, 2026
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|